These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1728505)

  • 1. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure.
    Packer M
    Circulation; 1992 Jan; 85(1 Suppl):I50-6. PubMed ID: 1728505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmias and sudden death in heart failure.
    Stevenson WG; Sweeney MO
    Jpn Circ J; 1997 Sep; 61(9):727-40. PubMed ID: 9293402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy.
    Chakko CS; Gheorghiade M
    Am Heart J; 1985 Mar; 109(3 Pt 1):497-504. PubMed ID: 3976476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure.
    Stevenson WG; Stevenson LW; Weiss J; Tillisch JH
    Am Heart J; 1988 Dec; 116(6 Pt 1):1447-54. PubMed ID: 3195428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmias and sudden death after dynamic cardiomyoplasty.
    Bocchi EA; Moreira LF; de Moraes AV; Bacal F; Sosa E; Stolf NA; Bellotti G; Jatene AD; Pilleggi F
    Circulation; 1994 Nov; 90(5 Pt 2):II107-11. PubMed ID: 7955235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden death in idiopathic dilated cardiomyopathy: role of ventricular arrhythmias.
    Larsen L; Markham J; Haffajee CI
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1051-9. PubMed ID: 7685884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sudden death and chronic cardiac insufficiency].
    Galinier M; Boveda S; Alhabaj S; Armengaud J; Cabrol P; Dongay B; Massabuau P; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12 Suppl):7-14. PubMed ID: 9891814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death, ventricular arrhythmias and hypertensive left ventricular hypertrophy.
    Dunn FG; Pringle SD
    J Hypertens; 1993 Oct; 11(10):1003-10. PubMed ID: 8258663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators.
    Teerlink JR; Jalaluddin M; Anderson S; Kukin ML; Eichhorn EJ; Francis G; Packer M; Massie BM
    Circulation; 2000 Jan 4-11; 101(1):40-6. PubMed ID: 10618302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of ventricular arrhythmias in relation to sudden cardiac death: therapeutic implications.
    Surawicz B
    J Am Coll Cardiol; 1987 Aug; 10(2):435-47. PubMed ID: 3298363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular diseases as a cause of sudden death in athletes].
    Halawa B
    Pol Merkur Lekarski; 2004 Jan; 16(91):5-7. PubMed ID: 15074012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmias in heart failure: current concepts of mechanisms and therapy.
    Eckardt L; Haverkamp W; Johna R; Böcker D; Deng MC; Breithardt G; Borggrefe M
    J Cardiovasc Electrophysiol; 2000 Jan; 11(1):106-17. PubMed ID: 10695472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia.
    Packer M; Gottlieb SS; Kessler PD
    Am J Med; 1986 Apr; 80(4A):23-9. PubMed ID: 2871753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sudden death in competitive athletes].
    Juszczyk Z
    Wiad Lek; 2007; 60(3-4):155-7. PubMed ID: 17726868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.